Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company is expected to implement a product focus and stable pricing strategy in 2025, leading to improved gross margins in the first three quarters. The main brand shows strong resilience, while the sub-brand Aikeman is experiencing breakthroughs, indicating a positive outlook for multi-brand growth to restore the company's growth momentum [2][11] - The forecast for EPS has been raised for 2025-2027 to 1.23 (+0.13), 1.56 (+0.08), and 1.90 (+0.18) yuan, respectively. A target PE of 38x for 2026 has been set, resulting in an updated target price of 59.28 yuan [11] Financial Summary - Total revenue is projected to be 5,522 million yuan in 2023, increasing to 5,736 million yuan in 2024, but decreasing to 5,479 million yuan in 2025, before rising to 6,059 million yuan in 2026 and 6,663 million yuan in 2027 [4] - Net profit attributable to the parent company is expected to decline from 757 million yuan in 2023 to 503 million yuan in 2024, with a slight recovery to 520 million yuan in 2025, and further increases to 663 million yuan in 2026 and 806 million yuan in 2027 [4] - The gross margin for the first three quarters of 2025 improved to 74.33%, a year-on-year increase of 0.6 percentage points [11] Market Performance - The company's stock price has ranged between 39.34 and 50.85 yuan over the past 52 weeks, with a total market capitalization of 20,138 million yuan [6] - The stock has shown an absolute increase of 17% over the past month, 13% over the past three months, and 18% over the past year [10] Brand Performance - The main brand, Winona, has streamlined its product series and focused on core products, achieving a ranking of 9th in the Tmall beauty industry during the Double Eleven shopping festival, maintaining its position in the top 10 for nine consecutive years [11] - The sub-brand Aikeman has seen significant growth, ranking 2nd in the Tmall beauty new brand transaction list during Double Eleven 2025, with key products achieving sales of over 100,000 units [11]

Group 1: Medical Aesthetics Industry - The Chinese medical aesthetics market is expected to reach nearly 370 billion yuan by 2025, with a compound annual growth rate (CAGR) of approximately 10% projected until 2030, potentially reaching 600 billion yuan [2][8][36] - The trend of "self-pleasure consumption" is prominent, with about 50% of users indicating that the reason for choosing medical aesthetics is that "becoming beautiful makes them happier" [8][11][15] - The consumer demographic is shifting towards younger individuals, with the proportion of users under 25 years old increasing from 26% in 2022 to 35% by 2025 [20][22][36] - Light medical aesthetics are becoming mainstream, accounting for 52% of the market in 2022, with a growing preference for non-invasive procedures [16][17][36] - The market for recombinant collagen is expected to grow significantly, with a projected CAGR of 41.4% from 2023 to 2027, potentially reaching 114.5 billion yuan [8][45] Group 2: Beauty Industry - The retail sales of cosmetics in China are projected to grow at a CAGR of approximately 9% from 2016 to 2024, with a moderate recovery expected in 2025 [3][9] - The trend of "self-gifting" is becoming the primary scenario for beauty consumption, reflecting the strengthening of "self-pleasure consumption" [3][8] - The cosmetics raw materials market is expected to grow from 1147.8 billion yuan in 2019 to 1603.9 billion yuan by 2024, with a CAGR of 6.9% [3][9] - The ODM (Original Design Manufacturer) industry for cosmetics is projected to reach 62.29 billion yuan by 2025, with domestic brands gaining market share [3][9] Group 3: Related Companies on the Beijing Stock Exchange - Companies such as Jinbo Biological, which leads in recombinant collagen medical devices and is entering the functional skincare market, are expected to benefit from the ongoing growth in the beauty consumption sector [3][8] - Bawei Co., which provides ODM services for domestic and international cosmetic brands, is also positioned to gain from the industry's expansion [3][8] - Leading companies in cosmetic raw materials, such as Weiqi Technology and Jiakai Biological, are well-placed to capitalize on the industry's growth [3][8]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights Meituan's acquisition of Dingdong Maicai for approximately $717 million, aiming to enhance its instant retail supply chain efficiency. Dingdong Maicai has achieved profitability for 12 consecutive quarters and operates over 1,000 front warehouses in China, with a monthly purchasing user base exceeding 7 million [4][24][27] - The report emphasizes the importance of supply chain efficiency and product quality in the competitive landscape of the instant retail industry, suggesting that the focus will shift towards these aspects post-acquisition [27] Summary by Sections Industry Dynamics - Meituan's acquisition of Dingdong Maicai is expected to create synergies in supply chain, regional layout, and warehouse scale, enhancing operational efficiency in the East China region [24][27] - Dingdong Maicai's established direct sourcing and self-operated production capabilities are anticipated to be preserved and amplified within Meituan's platform [27] Investment Themes - Investment Theme 1: Focus on high-end and fashionable gold jewelry brands, recommending companies like Laopuhuangjin and Chaohongji, which are expected to benefit from the emotional consumption trend [6][29] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, with recommendations for Yonghui Supermarket and Aiyingshi [6][29] - Investment Theme 3: Highlight domestic beauty brands that cater to emotional value and innovative safe ingredients, recommending brands like Maogeping and Pola [6][29] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading chain medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [6][29] Market Performance - The retail and social service indices reported a slight decline of 0.34% and a slight increase of 0.02% respectively during the week of February 2 to February 6, 2026 [14][15] - The brand cosmetics sector showed the highest weekly increase of 4.99%, while the watch and jewelry sector led with a year-to-date increase of 16.56% [16][19] Company Highlights - Laopuhuangjin reported a significant revenue increase of 250.9% in FY2025H1, driven by brand expansion and customer base growth [31][32] - Chaohongji is expected to achieve a net profit growth of 125% to 175% in 2025, supported by differentiated product strength and multi-channel marketing [31][32] - Meilitiantian Medical Health anticipates a net profit increase of at least 34% in 2025, driven by both internal growth and acquisitions [39][40]

商贸零售 行 业 研 究 2026 年 02 月 08 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% -12% 0% 12% 24% 36% 2025-02 2025-06 2025-10 商贸零售 沪深300 相关研究报告 《功效护肤品牌 HBN 母公司护家科 技递表港交所—行业周报》-2026.2.1 《老铺黄金 SKP 活动开启，关注春节 销售超预期催化 — 行 业 周 报 》 -2026.1.25 《2025 年社零同比+3.7%，海南封关 首 月 表 现 亮 眼 — 行 业 点 评 报 告 》 -2026.1.19 行业关键词：霸王茶姬、琳朝珠宝、阿嬷手作、壹网壹创、千问等 【霸王茶姬】霸王茶姬开设首家泰国旗舰店。 【琳朝珠宝】琳朝珠宝全国第二家门店落子南京德基广场。 【阿嬷手作】阿嬷手作跨界试水餐饮，推出高端广西风味螺蛳粉。 【壹网壹创】壹网壹创拟并购 AI 营销公司。 【千问】千问 APP 上线 AI 请奶茶活动引爆流量。 板块行情回顾 本周（2 月 2 日-2 月 6 日），商贸零售和社会服务指数分别报收 2426.99 点/9285.47 点，分别下跌 0.34%/上涨 ...

Group 1: Medical Aesthetics Industry - The Chinese medical aesthetics market is expected to reach nearly 370 billion by 2025, with a high growth outlook for the recombinant collagen segment [2][35] - The trend of younger consumers in medical aesthetics is evident, with light medical aesthetics gradually becoming mainstream, accounting for 52% of the market in 2022 [7][12] - Approximately 50.90% of users choose medical aesthetics because "becoming beautiful can make oneself happier," indicating a strong emotional value associated with beauty [4][8] Group 2: Beauty Industry - The retail sales of cosmetics in China are projected to grow at a CAGR of about 9% from 2016 to 2024, with domestic brands expected to maintain growth momentum [2][3] - The Chinese cosmetics market is entering a phase of high-quality development, with trends leaning towards scientific beauty and Eastern philosophies [3][19] - The market for cosmetic raw materials is expected to grow from 1147.80 billion in 2019 to 1603.90 billion by 2024, with a CAGR of 6.9% [2][3] Group 3: Related Companies on the Beijing Stock Exchange - Companies such as Jinbo Biological, which leads in recombinant human collagen medical devices, and Bawei Co., which provides ODM services for domestic and international cosmetic brands, are expected to benefit from the ongoing beauty consumption boom [2][3] - The market for functional skincare products is also seeing new entrants, with companies like Jinbo Biological expanding into this segment [2][3] - The beauty industry is experiencing a transformation driven by technological innovations, including synthetic biology and the application of new materials [2][3]

内容只是个人观点，仅供参考，不作为投资依据！欢迎关注交流，互相学习、共同探讨！ 恒生互联网跳空低开后超跌反弹，盘中一度下跌2.56%，截至目前下跌1.57%。其中快手下跌2.73%，腾 讯控股下跌2.42%，阿里巴巴下跌2.38%，商汤下跌2.11%；地平线机器人逆势上涨2.76%。 银行探底回升，截至目前下跌0.09%，盘中一度下跌0.69%。其中渣打银行下跌2.51%，大新银行下跌 1.43%，汇丰控股下跌1.29%，中银香港下跌1.08%；招商银行逆势上涨2.11%。 开盘后直线跳水，盘中一度大跌1.6%，随后超跌反弹，截至目前下跌0.86%。互联网跌幅居前，恒生医 疗、科技等紧随其后，大消费逆势红盘。 大消费相对抗跌，低开高走，盘中会有波折但趋势明显，截至目前下跌0.27%。其中百胜中国大涨 8.26%，巨子生物上涨5.6%，名创优品上涨5.25%；翰森制药、信达生物、康方生物等股跌幅均在3%上 方。 ...

Group 1: Food and Beverage Industry - The recent strong rally in the liquor sector is driven by a combination of macro policies, valuation adjustments, and fundamental factors, rather than a single catalyst [4][8][9] - Optimized real estate policies and supportive domestic demand measures have effectively boosted market expectations for consumption recovery [8][9] - The valuation of the liquor sector has returned to historical lows, with public fund holdings in the sector dropping to 2.9% in Q4 2025, indicating a clearer and more reasonable chip structure [8][9] - The strong performance of leading companies like Kweichow Moutai in terms of pricing and sales has confirmed the resilience of terminal demand in the liquor market [8][9] Group 2: Retail and Cosmetics Industry - The medical beauty and cosmetics sectors have shown significant growth, with notable stock performances in January, such as Four Seasons Medicine (+28.5%) and 壹网壹创 (+50.8%) [6][26][27] - Medical beauty company Giant Bio received approval for a new product, showcasing its R&D strength and market potential [27] - 美丽田园 has announced positive earnings forecasts, reflecting strong operational resilience and growth potential through strategic acquisitions and store expansions [27][30] Group 3: Semiconductor Materials Industry - The sputtering target market is expected to grow significantly, with projections indicating a global market size of 25.1 billion yuan by 2027 for semiconductor sputtering targets [15] - The supply side is dominated by overseas giants, but domestic manufacturers are transitioning from being mere substitutes to becoming global competitors [17][18] - Price increases in sputtering materials are anticipated due to rising metal costs, with major clients likely to accept these price hikes [16][18] Group 4: Cloud Computing and AI Industry - Google Cloud's revenue for Q4 2025 reached $17.7 billion, a 48% year-on-year increase, exceeding analyst expectations [20][21] - Capital expenditures for Google reached $27.9 billion in Q4 2025, a 95% increase year-on-year, with projections for 2026 capital expenditures between $175 billion and $185 billion [20][21] - Meta and Microsoft also reported strong revenue growth, driven by AI efficiencies, with Meta's Q4 revenue at $59.893 billion, a 24% increase [21][22]

智通财经APP获悉，港股恒生指数跌1.27%，跌340点，报26506点；恒生科技指数跌1.16%。港股早盘成 交1683亿港元。 腾讯控股（00700）股价跌2.87%，市值跌破5万亿港元。 名创优品(09896)逆市涨超5%，首度与央视总台春晚进行合作，"兴趣消费"战略迎关键性跃升。 巨子生物(02367)盘中涨超4%，全球首个注射用重组胶原蛋白和透明质酸钠复合溶液获批。 中通快递-W(02057)涨2.35%，2025年包裹量同比增长13.3%，拟溢价约37.5%发行15亿美元票据。 钧达股份(02865)回吐逾10%，行业协会发声太空光伏技术仍处探索初期。 煤炭股普遍回落。兖煤澳大利亚(03668)、首钢资源(00639)均跌超6%。 隔夜AMD暴跌影响芯片股。华虹半导体(01347)跌超5%，兆易创新(03986)跌超5%。 黄金股再度走低。国际黄金市场波动加剧，机构称贵金属根本逻辑并未改变。中国黄金国际(02099)跌 6.8%；紫金矿业(02899)跌6%。 餐饮股涨幅居前，餐饮行业经营态势持续回暖，机构称龙头企业率先凸显配置价值。百胜中国(09987) 涨8.7%；海底捞(06862)涨2.5 ...

Group 1: Insurance Sector - Insurance stocks are experiencing significant declines, with China Life (02628) down 3.75%, New China Life (01336) down 3.28%, and China Pacific Insurance (02601) down 2.74%. The government plans to issue approximately 200 billion yuan in special bonds to inject capital into major insurance companies, marking the first time this method will be used for insurance firms in China [1] Group 2: Logistics and Delivery - ZTO Express (02057) has seen an increase of over 2.3%. The company estimates that its total revenue for 2025 will be between 48.5 billion yuan and 50 billion yuan, representing a growth of approximately 9.5% to 12.9% compared to 44.2807 billion yuan in 2024 [1] Group 3: Biotechnology - Innovent Biologics (09969) has risen over 4%, with a current increase of 3.25%. The company anticipates achieving revenue of 2.37 billion yuan in 2025, a year-on-year growth of approximately 134%, and expects to turn a profit with a net profit of around 630 million yuan [1] Group 4: Coal Sector - Coal stocks are generally declining, with Yancoal Australia (03668) down 6.63%, Shougang Resources (00639) down 7.83%, and China Shenhua (01088) down 2.47%. This decline follows reports that the Indonesian government has proposed a production cut plan, leading to a 40% to 70% reduction in production quotas for major miners [2] Group 5: Medical Devices - GigaGen (02367) has increased over 8%, currently up 4.11%. The company recently announced that its "recombinant type I α1 collagen and sodium hyaluronate composite solution" has been approved as a medical device, marking a significant milestone as the first product of its kind for improving facial smoothness [2] Group 6: Semiconductor Sector - Semiconductor stocks are all declining, with Hua Hong Semiconductor (01347) down 5.91% and SMIC (00981) down 3.49%. This follows a significant drop in AMD's stock price by 17.31% after its fourth-quarter report indicated that while revenue exceeded expectations, the guidance for the first quarter was below market expectations [3] Group 7: Restaurant Sector - Restaurant stocks are performing well, with Yum China (09987) up 8.41% and Haidilao (06862) up 2.69%. The restaurant industry has shown signs of recovery, with retail sales in the sector growing by 3.8%, 3.2%, and 2.2% year-on-year in the last quarter of 2025, significantly outpacing overall retail growth [3] Group 8: Consumer Goods - Miniso (09896) has risen over 5.1% after announcing its partnership with the Central Radio and Television Station for the 2026 Spring Festival Gala. This collaboration is seen as a significant marketing move to elevate the brand's visibility in the mainstream market [4] Group 9: Gold Sector - Gold stocks are declining, with China Gold International (02099) down 6.8% and Zijin Mining (02899) down 6.29%. Recent volatility in the international gold market has been noted, with expectations that geopolitical tensions and liquidity easing by the Federal Reserve may drive gold prices higher [4] Group 10: Cryptocurrency - Cryptocurrency ETFs and related stocks are continuing to decline, with significant drops in prices, including Bitcoin falling below $72,000 for the first time in 15 months. The price has decreased by over 42% from its peak last October [5] Group 11: US Market Highlights - Boston Scientific (BSX.US) fell 17.59% after providing lower-than-expected guidance for fiscal year 2026. The company expects adjusted earnings per share to be between $3.43 and $3.49, slightly below analyst expectations [6] - Solar stocks surged, with Enphase Energy (ENPH.US) rising 38.6% following reports of interest from Elon Musk's teams in the Chinese solar supply chain [6]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the strong performance of the medical beauty and cosmetics sectors, with significant growth potential driven by consumer demand for emotional value and safety in products [8][50] - Key companies in the medical beauty sector include Meili Tianyuan Medical Health, which is expanding through acquisitions and strong operational strategies, and in the cosmetics sector, brands like HBN and Banmu Huatian are leading with innovative product offerings and market strategies [8][24][34] Summary by Sections Market Review - The beauty and personal care index rose by 0.44% in January, ranking 24th among all sectors, underperforming the overall market [14][15] - Notable stock performances in January included SiHuan Pharmaceutical (+28.5%) and Yonghe Medical (+22.7%) in the medical beauty sector, while Yiwan Yichuang (+50.8%) and Ruoyu Chen (+8.1%) led in cosmetics [5][15] Medical Beauty - The approval of a new composite solution by Juzhi Biotechnology marks a significant advancement in the field, showcasing the company's R&D capabilities [6][19] - Meili Tianyuan announced a positive earnings forecast, projecting revenues of at least 3 billion yuan for 2025, reflecting a growth of over 16% year-on-year [22] Cosmetics - Banmu Huatian's parent company has filed for an IPO, aiming to leverage its strong market position in body care products [24] - HBN, a leading domestic skincare brand, has also submitted its IPO application, highlighting its innovative product lines and strong sales performance [34] Investment Recommendations - The report recommends focusing on high-quality companies in the medical beauty and cosmetics sectors that cater to emotional consumption trends, with specific mentions of Meili Tianyuan, Aimeike, and Ruoyu Chen among others [8][49] - In cosmetics, brands like Maogeping and Porlaia are highlighted for their strong market positions and innovative strategies [50][52]